Dynamic changes of the sympathetic nervous system in the bone marrow in myeloid leukaemia
The Journal of Biochemistry · 01.07.2026 · 180 (1) · 75-82
DOI: 10.1093/jb/mvag028 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Biochemistry, online erschienen am 13.04.2026. Verfasst von Sayumi Okigawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Institute for Life and Medical Sciences, Kyoto University, Shogoin Kawaharacho 53, Sakyo, Kyoto 606-8507, Japan. Hauptthemen laut MEDLINE: Sympathetic Nervous System, Bone Marrow, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid. Die Arbeit nennt 34 Literaturangaben. Gefördert von: The Medical Research Support Centre and Innovative Support Alliance for Life Science core facility at Kyoto University was supported in part by the AMED, the Kyoto University LiMe Office of Directors' Research Grants Program, Japan Agency for Medical Research and Development (AMED).
Abstract (Originalsprache)
Chronic myeloid leukaemia (CML) is a hematologic malignancy originating from hematopoietic stem cells with the fusion oncogene BCR–ABL1 on the Philadelphia chromosome, which drives the abnormal proliferation of leukemic blast cells within the bone marrow microenvironment. While previous research has primarily focused on the hematopoietic compartment, the functional contribution of the bone marrow microenvironment to the CML pathology remains understudied. We investigated the changes in the peripheral nervous system in the bone marrow with myeloid leukaemia via immunofluorescence staining of tyrosine hydroxylase (TH) and calcitonin gene-related peptide (CGRP) antibodies in mouse with NUP98–HOXA9– and BCR–ABL1–expressing myeloid leukaemia. We found that the TH-positive fibres were significantly reduced, while no overt changes were observed in CGRP-positive nerves in the bone marrow. The reduction in TH-positive nerve cells was also evident in the spleen. Human patient gene expression data suggested that the levels of sympathetic nerve receptor expression change during the blastic transformation of human CML. Our findings indicate that the sympathetic nervous system regulates the pathogenesis of myeloid leukaemia and could play a crucial role in the disease progression of myeloid leukaemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Institute for Life and Medical Sciences, Kyoto University, Shogoin Kawaharacho 53, Sakyo, Kyoto 606-8507, Japan.
ORCID-Profile: Takahiro Ito
Förderung
- The Medical Research Support Centre and Innovative Support Alliance for Life Science core facility at Kyoto University was supported in part by the AMED
- the Kyoto University LiMe Office of Directors' Research Grants Program
- Japan Agency for Medical Research and Development (AMED)
- Japan Science and technology Agency (JST)
- Japan Society for the Promotion of Science (JSPS)/the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- the Kyoto University LiMe Office of Directors’ Research Grants Program
Zitieren
APA
Okigawa, S., Inafuku, H., Hattori, A., & Ito, T. (2026). Dynamic changes of the sympathetic nervous system in the bone marrow in myeloid leukaemia. The Journal of Biochemistry, 180(1), 75-82. https://doi.org/10.1093/jb/mvag028
Vancouver
Okigawa S, Inafuku H, Hattori A, Ito T. Dynamic changes of the sympathetic nervous system in the bone marrow in myeloid leukaemia. The Journal of Biochemistry. 2026;180(1):75-82. doi:10.1093/jb/mvag028
BibTeX
@article{Okigawa2026,
author = {Okigawa, Sayumi and Inafuku, Hibiki and Hattori, Ayuna and Ito, Takahiro},
title = {Dynamic changes of the sympathetic nervous system in the bone marrow in myeloid leukaemia},
journal = {The Journal of Biochemistry},
year = {2026},
volume = {180},
number = {1},
pages = {75--82},
doi = {10.1093/jb/mvag028}
}
EUVIMED